{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Endocrinology & Hormones > Testosterone PropionateCAS：57-85-2
Molecular Formula：C22H32O3
Molecular Weight：344.49
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 57-85-2 |
| Name | Testosterone Propionate |
| Molecular Formula | C22H32O3 |
| Molecular Weight | 344.49 |
| Solubility | Soluble in DMSO ≥25mg/mL;Soluble in Methanol/Ethanol ≥50mg/mL;Soluble in Water ＜ 1mg/mL |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| EC | EINECS 200-351-1 |
| MDL | MFCD00003653 |
| SMILES | C[C@@]12[C@@H](OC(CC)=O)CC[C@@]1([H])[C@]3([H])CCC4=CC(CC[C@]4(C)[C@@]3([H])CC2)=O |
| InChIKey | PDMMFKSKQVNJMI-BLQWBTBKSA-N |
| InChI | InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1 |
| PubChem CID | 5995 |
| Target Point | Androgen Receptor |
| Passage | Endocrinology & Hormones |
| Background | Testosterone Propionate is an androgenic and anabolic steroid that is reported to have anti-estrogenic, endometrial growth and ovarian-pituitary functions. |
| Unit | Bottle |
| Specification | 50mg 10mM*1mL in DMSO 100mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Zang L, et al. J Cell Mol Med. 2021 Jun;25(12)5753-5768.
Zang L, et al. J Cell Mol Med. 2021 Jun;25(12)5753-5768.
Zang L, et al. J Cell Mol Med. 2021 Jun;25(12)5753-5768.
Zang L, et al. J Cell Mol Med. 2021 Jun;25(12)5753-5768.
Sorry, there is no more information.
Association between circadian rhythm disruption and polycystic ovary syndrome
Click to check >>Author：Wang F; Xie N; Wu Y; Zhang Q; Zhu Y; Dai M; Zhou J
IF：6.7000
Publish_to：Fertil Steril
PMID：33358334
Qianliexin capsule exerts anti-inflammatory activity in chronic non-bacterial prostatitis and benign prostatic hyperplasia via NF-κB and inflammasome
Click to check >>Author：Zang L. Tian F. Yao Y. Chen Y. Shen Y. Han M. Meng
IF：4.8290
Publish_to：J Cell Mol Med
PMID：33982874
Leptin promotes epithelial-mesenchymal transition in benign prostatic hyperplasia through downregulation of BAMBI
Click to check >>Author：Zhang B;Chen X;Xie C;Chen Z;Liu Y;Ru F;He Y.
IF：3.7000
Publish_to：Exp Cell Res
PMID：31805276
Manual Download
